Answer
Evolocumab (Repatha SureClick) is contraindicated in patients with hypersensitivity to evolocumab or any of its excipients.
Sources for this answer
- Repatha SureClickAmgen Ltd · emc · SmPC §4.3 Contraindications · Version 24Document updated
Sources checked